CAS 69304-47-8: Brivudine
Formula:C11H13BrN2O5
InChI:InChI=1S/C11H13BrN2O5/c12-2-1-6-4-14(11(18)13-10(6)17)9-3-7(16)8(5-15)19-9/h1-2,4,7-9,15-16H,3,5H2,(H,13,17,18)/b2-1+/t7-,8+,9+/m0/s1
InChI key:InChIKey=ODZBBRURCPAEIQ-PIXDULNESA-N
SMILES:O=C1NC(=O)N(C=C1C=CBr)C2OC(CO)C(O)C2
- Synonyms:
- (E)-5-(2-Bromovinyl)deoxyuridine
- (E)-5-(2-bromovinyl)-2'-deoxyuridine
- (E)-5-O-(2-bromoethenyl)-2′-deoxyuridine
- 5-[(1E)-2-Bromoethenyl]-2′-deoxyuridine
- 5-[(E)-2-bromoethenyl]-1-(2-deoxy-beta-L-erythro-pentofuranosyl)pyrimidine-2,4(1H,3H)-dione
- 5-[(E)-2-bromoethenyl]-2'-deoxyuridine
- Brivudin
- Bromovinyldeoxyuridine
- E-5-(2-Bromovinyl)-2'-Deoxy-Uridine
- Helpin
- See more synonyms
- N-(2,6-dichloro-4-{[(2-chloroethyl)(methyl)amino]methyl}phenyl)-4,5-dihydro-1H-imidazol-2-amine dihydrochloride
- Rp 101
- Uridine, 5-(2-bromoethenyl)-2′-deoxy-, (E)-
- Uridine, 5-[(1E)-2-bromoethenyl]-2′-deoxy-
- BVDU

(E)-5-(2-Bromovinyl)-2'-deoxyuridine
CAS:69304-47-8
Formula:
C11H13BrN2O5
Purity:
>98.0%(T)(HPLC)
Color and Shape:
White to Almost white powder to crystal
Molecular weight:
333.14
Ref: 3B-B3404
100mg | 127.00 € |
Estimated delivery in United States, on Friday 21 Mar 2025

Brivudine, 98%
CAS:69304-47-8
It is used as pharmaceutical intermediate. This Thermo Scientific Chemicals brand product was originally part …
Formula:
C11H13BrN2O5
Purity:
98%
Color and Shape:
Crystalline powder or powder, White to pale cream
Molecular weight:
333.14
Ref: 02-H27853
1g | 506.00 € | ||
50mg | To inquire | ||
250mg | 167.00 € |
Estimated delivery in United States, on Monday 24 Mar 2025

Ref: IN-DA003OJV
1g | 175.00 € | ||
5g | To inquire | ||
50mg | 53.00 € | ||
250mg | 113.00 € | ||
3.5kg | 36,422.00 € |
Estimated delivery in United States, on Friday 28 Mar 2025

Brivudine
CAS:69304-47-8
Brivudine (BVDU), an antiviral medicine, is used in the therapy of herpes zoster.
Formula:
C11H13BrN2O5
Purity:
99.51% - 99.85%
Color and Shape:
Solid
Molecular weight:
333.14
Ref: TM-T0718
25mg | 47.00 € | ||
50mg | 60.00 € | ||
100mg | 79.00 € | ||
200mg | 97.00 € | ||
500mg | 156.00 € | ||
1mL*10mM (DMSO) | 50.00 € |
Estimated delivery in United States, on Friday 28 Mar 2025

Ref: 4Z-B-087007
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Monday 31 Mar 2025

Ref: 54-OR1008352
1g | 259.00 € | ||
5g | 960.00 € | ||
100mg | 73.00 € | ||
250mg | 116.00 € |
Estimated delivery in United States, on Monday 31 Mar 2025

5-(E)-(2-Bromovinyl)-2''-deoxyuridine
CAS:69304-47-8
Formula:
C11H13BrN2O5
Purity:
≥ 98.0%
Color and Shape:
White to off-white powder
Molecular weight:
333.14
Ref: 7W-GN2626
50mg | 148.00 € |
Estimated delivery in United States, on Monday 31 Mar 2025

Brivudine
CAS:69304-47-8
Formula:
C11H13BrN2O5
Color and Shape:
White To Off-White Solid
Molecular weight:
333.14
Ref: 4Z-B-087001
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Monday 31 Mar 2025

Brivudine
CAS:69304-47-8
Applications Brivudine is a nucloside analog which causes induction of neuronal differentiation in human reporter …
Formula:
C11H13BrN2O5
Color and Shape:
Neat
Molecular weight:
333.14
Ref: TR-B677670
50mg | 174.00 € | ||
100mg | 237.00 € | ||
500mg | 684.00 € |
Estimated delivery in United States, on Monday 7 Apr 2025

Ref: 10-F463475
1g | To inquire | ||
5g | To inquire | ||
50mg | To inquire | ||
250mg | To inquire |
Estimated delivery in United States, on Monday 7 Apr 2025

Brivudine
CAS:69304-47-8
Anti-viral; thymidine analogue; DNA plymerase inhibitor
Formula:
C11H13BrN2O5
Purity:
Min. 95%
Color and Shape:
White Powder
Molecular weight:
333.14 g/mol
Ref: 3D-NB03851
1g | 259.00 € | ||
5g | 669.00 € | ||
10g | 891.00 € | ||
25g | 1,434.00 € |
Estimated delivery in United States, on Tuesday 8 Apr 2025

Brivudine-13C4,15N2
Controlled ProductCAS:69304-47-8
Formula:
C7C4H13BrN2O5
Color and Shape:
Neat
Molecular weight:
339.09
Ref: TR-B677672
25mg | 27,041.00 € |
Estimated delivery in United States, on Thursday 8 May 2025